Scotiabank Maintains Sector Outperform on Bio-Techne, Raises Price Target to $88
Bio-Techne Corporation +3.39%
Bio-Techne Corporation TECH | 71.05 | +3.39% |
Scotiabank analyst Sung Ji Nam maintains Bio-Techne (NASDAQ:
TECH) with a Sector Outperform and raises the price target from $83 to $88.